AB 11. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with lung cancer and bone metastases

BACKGROUND: Breakthrough cancer pain (BTcP) represents an important clinical challenge in the care of patients with cancer. Oral opioids have traditionally been the only available drugs for BTcP. However, the onset and duration of action of oral opioids may not be suitable for treating many episodes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kallianos, Anastasios, Nikolokopoulou, Maria, Eleutheriou, Dimitra, Tsirovasilis, Petros, Maniakos, Nikos, Tsoukas, Dimitrios, Rapti, Aggeliki
Formato: Artigo
Lenguaje:Inglês
Publicado: Pioneer Bioscience Publishing Company 2012
Materias:
Abstract
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537363/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares